APA (7th ed.) Citation

Miramontes-González, J. P., Rodrigo-Alaíz, Á., Gabella-Martín, M., González-Calle, D., Carretero-Gómez, J., & Corral-Gudino, L. (2026). Rewriting Diabetes Therapy: How Incretin Modulation is Transforming Cardiovascular and Renal Outcomes. Diabetes Therapy, 17(3), 317. https://doi.org/10.1007/s13300-025-01829-1

Chicago Style (17th ed.) Citation

Miramontes-González, José Pablo, Álvaro Rodrigo-Alaíz, Miriam Gabella-Martín, David González-Calle, Juana Carretero-Gómez, and Luis Corral-Gudino. "Rewriting Diabetes Therapy: How Incretin Modulation Is Transforming Cardiovascular and Renal Outcomes." Diabetes Therapy 17, no. 3 (2026): 317. https://doi.org/10.1007/s13300-025-01829-1.

MLA (9th ed.) Citation

Miramontes-González, José Pablo, et al. "Rewriting Diabetes Therapy: How Incretin Modulation Is Transforming Cardiovascular and Renal Outcomes." Diabetes Therapy, vol. 17, no. 3, 2026, p. 317, https://doi.org/10.1007/s13300-025-01829-1.